{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,26]],"date-time":"2025-05-26T13:47:13Z","timestamp":1748267233907},"reference-count":8,"publisher":"Japanese Society of Internal Medicine","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2022,4,1]]},"DOI":"10.2169\/internalmedicine.7902-21","type":"journal-article","created":{"date-parts":[[2021,9,17]],"date-time":"2021-09-17T22:09:15Z","timestamp":1631916555000},"page":"1063-1065","source":"Crossref","is-referenced-by-count":2,"title":["Two Lambert-Eaton Myasthenic Syndrome Patients with Ameliorated Activities of Daily Living Due to Cholinesterase Inhibitors"],"prefix":"10.2169","volume":"61","author":[{"given":"Hiroshi","family":"Yamasaki","sequence":"first","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hyogo-Chuo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naonobu","family":"Futamura","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hyogo-Chuo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itaru","family":"Funakawa","sequence":"additional","affiliation":[{"name":"Department of Neurology, National Hospital Organization Hyogo-Chuo National Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuo","family":"Kohara","sequence":"additional","affiliation":[{"name":"Department of Neurology, Kobe City Medical Center General Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunsuke","family":"Yoshimura","sequence":"additional","affiliation":[{"name":"Department of Neurology and Strokology, Nagasaki University Hospital, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masakatsu","family":"Motomura","sequence":"additional","affiliation":[{"name":"Medical Engineering Course, Department of Engineering, The Faculty of Engineering, Nagasaki Institute of Applied Science, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","unstructured":"1. Ministry of Health, Labor and Welfare Intractable Diseases (Neuroimmune Diseases) Policy and Practical Application Research Group. Joint group meeting abstracts. 2018: 12-13."},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Oh SJ. Amifampridine for the treatment of Lambert-Eaton myasthenic syndrome. Expert Rev Clin Immunol 15: 991-1007, 2019.","DOI":"10.1080\/1744666X.2020.1670061"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Motomura M, Johnston I, Lang B, Vincent A, Newsom-Davis J. An improved diagnostic assay for Lambert-Eaton myasthenic syndrome. J Neurol Neurosurg Psychiatry 58: 85-87, 1995.","DOI":"10.1136\/jnnp.58.1.85"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Wirtz PW, Verschuuren JJ, van Dijk JG, et al. Efficacy of 3,4-diaminopyridine and pyridostigmine in the treatment of Lambert-Eaton myasthenic syndrome: a randomized, double-blind, placebo-controlled, crossover study. Clin Pharmacol Ther 86: 44-48, 2009.","DOI":"10.1038\/clpt.2009.35"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Oh SJ, Kim DS, Kwon KH, Tseng A, Mussell H, Claussen GC. Wide spectrum of symptomatic treatment in Lambert-Eaton myasthenic syndrome. Ann N Y Acad Sci 841: 827-831, 1998.","DOI":"10.1111\/j.1749-6632.1998.tb11025.x"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Titulaer MJ, Lang B, Verschuuren JJ. Lambert-Eaton myasthenic syndrome: from clinical characteristics to therapeutic strategies. Lancet Neurol 10: 1098-1107, 2011.","DOI":"10.1016\/S1474-4422(11)70245-9"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Maddison P, Lang B, Mills K, Newsom-Davis J. Long term outcome in Lambert-Eaton myasthenic syndrome without lung cancer. J Neurol Neurosurg Psychiatry 70: 212-217, 2001.","DOI":"10.1136\/jnnp.70.2.212"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Denys EH, Lennon VA. Asymptomatic Lambert-Eaton syndrome. Muscle Nerve 49: 764-767, 2014.","DOI":"10.1002\/mus.24126"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_7902-21\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T03:41:06Z","timestamp":1648870866000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/61\/7\/61_7902-21\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,1]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.7902-21","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,1]]},"article-number":"7902-21"}}